Biotech & Longevity Plays

GLP-1 & gene therapies target oncology/longevity; LLY & NOVO lead with 45%+ YTD on M&A and epigenetic resets.

Compare up to 10 stocks

Comparison Ideas 5g Stocks AAPL vs. MSFT (Apple vs. Microsoft)AAPL vs. NVDA (Apple vs. Nvidia)Adtech Stocks Aerospace and Defense Stocks Airline Stocks AMD vs. INTC (AMD vs. Intel)AMZN vs. GOOGL AMZN vs. WMT (Amazon vs. Walmart)Artificial Intelligence Stocks AVGO vs. QCOM (Broadcom vs. Qualcomm)Bank Stocks Batmmaan Stocks Beer & Beverage Stocks Biotech & Longevity Plays Biotech Stocks Bitcoin Stocks Blockchain Stocks Blue Chip Stocks Cannabis Stocks Casino Stocks ChatGPT Stocks Chinese Stocks Chip Stocks Cloud & Storage Stocks COST vs. WMT (Costco vs. Walmart)Cryptocurrency Stocks Cybersecurity Stocks Data Center & AI Infrastructure Stocks Dividend Stocks Electric Vehicle Stocks Energy Stocks F vs. GM (Ford vs. General Motors)FAANG Stocks Gold Stocks GOOGL vs. META (Alphabet vs. Meta)Green Energy Stocks Green Hydrogen Stocks Growth Stocks HD vs. LOW (Home Depot vs. Lowe's)Healthcare Stocks Highest PE Ratio Stocks Hotel Stocks International Value Diversifiers Stocks Japanese Stocks JPM vs. BAC (JPMorgan vs. Bank of America)KO vs. PEP (Coca-Cola vs. PepsiCo Large Cap Stocks Lowest P/E Ratio Stocks Magnificent 7 Stocks Mega Cap Stocks Meme Stocks Metaverse Stocks MSFT vs. GOOGL vs. AMZN (Cloud Wars)MSFT vs. META (Microsoft vs. Meta)Nuclear Energy Revival Stock Nuclear Stocks NVDA vs. AMD vs. INTC (Chip Giants)NVDA vs. TSM (Nvidia vs. Taiwan Semi)Oil Stocks Onshoring & Rare Earths Supply Stocks OpenAI Stocks Popular BDC Stocks Private Credit & Fintech Risers PYPL vs. XYZ (PayPal vs. Block)Quantum Computing Innovators Stocks Quantum Computing Stocks Robotics & Autonomous Systems Stocks Social Media Stocks Solar Stocks Tech Stocks Top Robotics Stocks (Medical, AI & Industrial)Top Silver Stocks Trump Tariff Risk Stocks (Retail & Tech)Trump Tariff Winners (Steel, Manufacturing & Auto)TSLA vs. F vs. GM (Auto Wars)TSLA vs. LCID (Tesla vs. Lucid)TSLA vs. RIVN (Tesla vs. Rivian)Utility Stocks V vs. MA (Visa vs. Mastercard)V vs. MA vs. AXP (Credit Cards)Value Stocks Venezuela Oil Recovery (Energy & Services)Venezuela Seized Assets (Consumer/Industrial)Virtual Reality Stocks WallStreetBets Stocks

RESET ALL

LLY

NVO

ARQT

EXAS

TNGX

INSM

Biotech & Longevity Plays

Clear All

Compared Stocks: 6 / 10

Comparison Results

Name	Sector	Price	Volume	Market Cap	P/E Ratio	Dividend Yield	Analyst Consensus	Analyst Price Target
LLY	Healthcare	$1017.97	3.09M	$992.40B	45.84	0.59%	Strong Buy	xxxxxxxxxxxxx
NVO	Healthcare	$37.76	22.06M	$166.85B	10.74	4.94%	Hold	xxxxxxxxxxxxx
ARQT	Healthcare	$24.76	2.05M	$3.35B	―	―	Strong Buy	xxxxxxxxxxxxx
EXAS	Healthcare	$103.35	1.78M	$19.73B	―	―	Hold	xxxxxxxxxxxxx
TNGX	Healthcare	$11.53	1.92M	$1.50B	―	―	Strong Buy	xxxxxxxxxxxxx
INSM	Healthcare	$146.32	2.67M	$32.19B	―	―	Strong Buy	xxxxxxxxxxxxx

Top 10 Popular Investment Themes

Quantum Computing Stocks Dividend Stocks Magnificent 7 Stocks Nuclear Stocks Oil Stocks Tech Stocks Blue Chip Stocks Energy Stocks Bank Stocks Gold Stocks

Popular Stock Pairs

AAPL vs. MSFT (Apple vs. Microsoft)AAPL vs. NVDA (Apple vs. Nvidia)AMD vs. INTC (AMD vs. Intel)AMZN vs. GOOGL AMZN vs. WMT (Amazon vs. Walmart)AVGO vs. QCOM (Broadcom vs. Qualcomm)COST vs. WMT (Costco vs. Walmart)F vs. GM (Ford vs. General Motors)GOOGL vs. META (Alphabet vs. Meta)HD vs. LOW (Home Depot vs. Lowe's)JPM vs. BAC (JPMorgan vs. Bank of America)KO vs. PEP (Coca-Cola vs. PepsiCo MSFT vs. GOOGL vs. AMZN (Cloud Wars)NVDA vs. AMD vs. INTC (Chip Giants)NVDA vs. TSM (Nvidia vs. Taiwan Semi)

Performance Comparison

LLY

Eli Lilly & Co

1,051.99

129.10

13.99%

NVO

Novo Nordisk

37.45

-50.17

-57.26%

ARQT

Arcutis Biotherapeutics

26.97

14.14

110.21%

EXAS

Exact Sciences

103.38

55.83

117.41%

TNGX

Tango Therapeutics

11.14

9.24

486.32%

INSM

Insmed

149.33

73.04

95.74%

Biotech & Longevity Plays Latest News

Compare up to 10 stocks

Biotech & Longevity Plays

RESET ALL

LLY

NVO

ARQT

EXAS

TNGX

INSM

Biotech & Longevity Plays

Clear All

Compared Stocks: 6 / 10

PPH, IHE, PJP: U.S. Pharmaceutical ETFs Offer Investors Innovation and Growth

Pharma is one of the most exciting areas of healthcare.

4h ago

IHE

IVZ

Morning News Wrap-Up 3/2/26: Monday’s Biggest Stock Market Stories!

Stocks were on a wild ride Monday alongside the war in the Middle East as traders seek safe investment.

6h ago

Novo Nordisk Employees Elect New Board Representatives Ahead of March AGM

An update from Novo Nordisk ( ($NVO) ) is now available. On 2 March 2026, Novo Nordisk employees completed the election of new employee representatives to the company’s board, filling

6h ago

NVO

Midday Fly By: Markets bounce back following U.S.-Israeli attacks on Iran

The major averages were lower throughout the morning but have bounced back near noon as markets react to news over the weekend of coordinated U.S.-Israeli strikes against Iran, as well

7h ago

Eli Lilly Stock (LLY) Falls as Rival Novo Nordisk Expands Weight-Loss Pill Manufacturing

The rivalry between the two pharma concerns is intensifying.

7h ago

LLY

NVO

Eli Lilly Expands Early-Stage Pipeline With New Phase 1 Study of LY4515100

Eli Lilly And Company ($LLY) announced an update on their ongoing clinical study. Eli Lilly and Company (LLY) is running a new early-stage trial called “A Study of LY4515100 in

7h ago

LLY

KURE vs. VHT: Comparing China and U.S. Healthcare ETFs

We used the TipRanks Compare ETFs Tool to analyze healthcare ETFs from China and the U.S. In the evolving landscape of healthcare investments, the KraneShares MSCI All China Health Care

9h ago

JNJ

LLY

Novo Nordisk Details Progress of 2026 Share Buyback Programme

Novo Nordisk ( ($NVO) ) just unveiled an announcement. On 4 February 2026, Novo Nordisk A/S launched a share repurchase programme under EU Safe Harbour rules as part of a

10h ago

NVO

Arcutis Biotherapeutics price target lowered to $35 from $37 at Mizuho

Mizuho lowered the firm’s price target on Arcutis Biotherapeutics (ARQT) to $35 from $37 and keeps an Outperform rating on the shares. The firm updated the company’s model post the

12h ago

ARQT

Novo Nordisk downgraded to Neutral from Buy at Goldman Sachs

Goldman Sachs analyst James Quigley downgraded Novo Nordisk (NVO) to Neutral from Buy with a price target of $41, down from $63. The firm cut estimates for CagriSema across diabetes

14h ago

NVO

Read the latest stock news and analysis from the TipRanks news team.

See All News >

Recent Analysts Ratings of Biotech & Longevity Plays Stocks

ARQT

xxxxxxxxxxxxx

Buy

xxxxxxxxxxxxx

Reiterated

2026-03-02

LLY

xxxxxxxxxxxxx

Buy

xxxxxxxxxxxxx

Reiterated

2026-02-26

INSM

xxxxxxxxxxxxx

Buy

xxxxxxxxxxxxx

Reiterated

2026-02-26

TNGX

xxxxxxxxxxxxx

Buy

xxxxxxxxxxxxx

Reiterated

2026-02-25

NVO

xxxxxxxxxxxxx

Hold

xxxxxxxxxxxxx

Reiterated

2026-02-24

EXAS

xxxxxxxxxxxxx

Hold

xxxxxxxxxxxxx

Reiterated

2026-02-17

ARQT

xxxxxxxxxxxxx

Hold

xxxxxxxxxxxxx

Reiterated

2026-02-27

ARQT

xxxxxxxxxxxxx

Buy

xxxxxxxxxxxxx

Reiterated

2026-02-26

ARQT

xxxxxxxxxxxxx

Buy

xxxxxxxxxxxxx

Reiterated

2026-02-26

ARQT

xxxxxxxxxxxxx

Buy

xxxxxxxxxxxxx

Reiterated

2026-02-26

All Ratings >

Most Recent Earnings of Biotech & Longevity Plays Stocks

LLY

Apr 30, 2026Before Open

$992.40B

$7.25

$17.61B

0.48

45.84

NVO

May 6, 2026Before Open

$166.85B

$0.93

$11.58B

1.93

10.74

ARQT

May 19, 2026TBA

$3.35B

-$0.06

$102.07M

―

EXAS

May 13, 2026TBA

$19.73B

-$0.17

$840.71M

―

TNGX

Mar 30, 2026TBA

$1.50B

-$0.32

$500.00K

―

INSM

Apr 30, 2026TBA

$32.19B

-$0.99

$300.92M

―

Compare Stocks Side-by-SideOur stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.Key Features of Our Stock Comparison

Comprehensive Analysis: Compare up to 10 stocks with detailed metrics including price, market cap, P/E ratio, dividend yield, and more.

Analyst Ratings: View consensus ratings from top Wall Street analysts and their price targets for each stock.

Performance Tracking: Analyze historical performance with interactive charts showing 3-month, 6-month, 1-year, YTD, 3-year, and 5-year returns.

Dividend Information: Evaluate dividend yield, payout ratio, and dividend growth for income-focused investors.

Earnings Data: Compare earnings per share (EPS), revenue growth, and profitability metrics across companies.

How to Use the Stock Comparison ToolSimply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 10 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.

Popular Stock ComparisonsInvestors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).

Why Compare Stocks?Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.

All Stock Comparison Categories

AAPL vs. MSFT (Apple vs. Microsoft)AMZN vs. GOOGL GOOGL vs. META (Alphabet vs. Meta)AAPL vs. NVDA (Apple vs. Nvidia)AMZN vs. WMT (Amazon vs. Walmart)AMD vs. INTC (AMD vs. Intel)AVGO vs. QCOM (Broadcom vs. Qualcomm)NVDA vs. TSM (Nvidia vs. Taiwan Semi)TSLA vs. RIVN (Tesla vs. Rivian)F vs. GM (Ford vs. General Motors)TSLA vs. LCID (Tesla vs. Lucid)V vs. MA (Visa vs. Mastercard)JPM vs. BAC (JPMorgan vs. Bank of America)PYPL vs. XYZ (PayPal vs. Block)HD vs. LOW (Home Depot vs. Lowe's)KO vs. PEP (Coca-Cola vs. PepsiCo COST vs. WMT (Costco vs. Walmart)NVDA vs. AMD vs. INTC (Chip Giants)MSFT vs. GOOGL vs. AMZN (Cloud Wars)TSLA vs. F vs. GM (Auto Wars)V vs. MA vs. AXP (Credit Cards)Quantum Computing Stocks Dividend Stocks Magnificent 7 Stocks Nuclear Stocks Oil Stocks Tech Stocks Blue Chip Stocks Energy Stocks Bank Stocks Gold Stocks Growth Stocks Bitcoin Stocks Meme Stocks Biotech Stocks Chinese Stocks Artificial Intelligence Stocks Cannabis Stocks Healthcare Stocks Value Stocks Airline Stocks Cybersecurity Stocks OpenAI Stocks Solar Stocks ChatGPT Stocks FAANG Stocks Green Energy Stocks Large Cap Stocks Utility Stocks Chip Stocks Blockchain Stocks Social Media Stocks Cryptocurrency Stocks Electric Vehicle Stocks Japanese Stocks Casino Stocks Metaverse Stocks Highest PE Ratio Stocks Mega Cap Stocks Hotel Stocks Green Hydrogen Stocks 5g Stocks Aerospace and Defense Stocks Batmmaan Stocks WallStreetBets Stocks Virtual Reality Stocks Cloud & Storage Stocks Lowest P/E Ratio Stocks Adtech Stocks Biotech & Longevity Plays Nuclear Energy Revival Stock Onshoring & Rare Earths Supply Stocks Popular BDC Stocks Private Credit & Fintech Risers Quantum Computing Innovators Stocks Robotics & Autonomous Systems Stocks Beer & Beverage Stocks International Value Diversifiers Stocks Data Center & AI Infrastructure Stocks MSFT vs. META (Microsoft vs. Meta)Top Robotics Stocks (Medical, AI & Industrial)Top Silver Stocks Trump Tariff Risk Stocks (Retail & Tech)Trump Tariff Winners (Steel, Manufacturing & Auto)Venezuela Oil Recovery (Energy & Services)Venezuela Seized Assets (Consumer/Industrial)

Biotech & Longevity Plays - FAQ

Which Biotech & Longevity Plays stocks have a "Strong Buy" analyst rating?

These Biotech & Longevity Plays stocks currently have a "Strong Buy" analyst rating consensus:

Eli Lilly & Co - Strong Buy, based on 21 analyst ratings, 18 Buy, 3 Hold, and 0 Sell.

Arcutis Biotherapeutics - Strong Buy, based on 9 analyst ratings, 8 Buy, 1 Hold, and 0 Sell.

Tango Therapeutics - Strong Buy, based on 4 analyst ratings, 4 Buy, 0 Hold, and 0 Sell.

Insmed - Strong Buy, based on 19 analyst ratings, 18 Buy, 1 Hold, and 0 Sell.

Are Biotech & Longevity Plays stocks overpriced?

Eli Lilly & Co's stock price is currently $1,017.97, and its average 12-month price target is $1,261.00.

Novo Nordisk's stock price is currently $37.76, and its average 12-month price target is $56.00.

Arcutis Biotherapeutics's stock price is currently $24.76, and its average 12-month price target is $33.89.

Exact Sciences's stock price is currently $103.35, and its average 12-month price target is $105.00.

Tango Therapeutics's stock price is currently $11.53, and its average 12-month price target is $16.50.

Insmed's stock price is currently $146.32, and its average 12-month price target is $217.29.

Which Biotech & Longevity Plays stocks pay dividends?

Eli Lilly & Co does not currently pay dividends.

Novo Nordisk currently pays a dividend of $0.92 which represents an annual dividend yield of 4.94%. Novo Nordisk's next Ex-dividend date is March 30, 2026 and its next payout date is April 8, 2026.

Arcutis Biotherapeutics does not currently pay dividends.

Exact Sciences does not currently pay dividends.

Tango Therapeutics does not currently pay dividends.

Insmed does not currently pay dividends.